Overview

Effectiveness of Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the effectiveness of antibiotic therapy for patients with acute exacerbations of mild-to-moderate chronic obstructive pulmonary disease.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Catalan Society of Family Medicine
Collaborator:
Fondo de Investigacion Sanitaria
Treatments:
Amoxicillin
Anti-Bacterial Agents
Antibiotics, Antitubercular
Clavulanic Acid
Clavulanic Acids
Criteria
Inclusion Criteria:

- Acute exacerbations (at least one criterion present: increase of dyspnoea, increase of
sputum production and/or increase of purulence) of

- patients older than 40 years old,

- smokers or ex-smokers of more than 10 pack-years,

- with COPD and FEV1 greater than 50%, diagnosed by spirometry and a predicted ratio
FEV1/FVC<0.7%.

Exclusion Criteria:

- Severe COPD (FEV1<50%)

- Pneumonia

- Active neoplasm

- Tracheotomy

- Criteria for hospitalisation

- Patients previously being on antibiotics

- Immunodepressed patients

- History of hypersensitivity to beta-lactams or intolerance to clavulanate

- Enrollment in other clinical trials

- Patients who refuse to take part in this study

- Patients who have not had a spirometry test for the past two years